Hyamedix ApS
Credit rating
Company information
About the company
Hyamedix ApS (CVR number: 39177749) is a company from FREDERIKSBERG. The company recorded a gross profit of 48.1 kDKK in 2023. The operating profit was -1930.8 kDKK, while net earnings were -2750.6 kDKK. The profitability of the company measured by Return on Assets (ROA) was -20.1 %, which can be considered poor and Return on Equity (ROE) was -86.8 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -63.5 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. Hyamedix ApS's liquidity measured by quick ratio was 1.2 which is at a high level. Thus, the company is in a strong financial position, with liquid assets surpassing current liabilities. It is well-prepared to cover short-term financial obligations.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | 1 384.49 | 1 401.99 | -2 704.59 | -2 134.12 | 48.09 |
EBIT | 15.00 | - 481.60 | -5 582.14 | -4 887.58 | -1 930.82 |
Net earnings | 8.14 | - 486.36 | -5 973.63 | -5 206.55 | -2 750.56 |
Shareholders equity total | 9.14 | 1 522.78 | -3 855.41 | -5 052.15 | -7 802.71 |
Balance sheet total (assets) | 1 098.40 | 2 251.32 | 3 561.17 | 1 853.44 | 4 484.00 |
Net debt | - 569.84 | -2 090.23 | -3 381.16 | -1 650.68 | -1 090.34 |
Profitability | |||||
EBIT-% | |||||
ROA | 1.4 % | -28.8 % | -115.5 % | -68.3 % | -20.1 % |
ROE | 160.5 % | -63.5 % | -235.0 % | -192.3 % | -86.8 % |
ROI | 58.4 % | -62.9 % | -146.1 % | -159.8 % | -168.6 % |
Economic value added (EVA) | 59.17 | - 453.43 | -5 696.24 | -4 523.94 | -1 829.18 |
Solvency | |||||
Equity ratio | 0.8 % | 67.6 % | -52.0 % | -73.2 % | -63.5 % |
Gearing | -29.4 % | ||||
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 1.0 | 3.1 | 2.7 | 3.8 | 1.2 |
Current ratio | 1.0 | 3.1 | 2.7 | 3.8 | 1.2 |
Cash and cash equivalents | 569.84 | 2 090.23 | 3 381.16 | 1 650.68 | 3 380.78 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | B | B | C | C | C |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.